Pneumonitis: Causes, Symptoms, Diagnosis, and Treatment of Lung Inflammation

What Is Pneumonitis?

Pneumonitis = inflammation of lung parenchyma (alveoli, interstitium) causing alveolar filling with inflammatory exudate. "Pneumonia" = infectious pneumonitis. "Pneumonitis" often used for non-infectious causes. Both impair gas exchange.

Etiological Classification

CategoryKey CausesMechanism
InfectiousBacteria (S. pneumoniae, Legionella), Viruses (Influenza, RSV, SARS-CoV-2), Fungi (Histoplasma, Aspergillus), Mycobacteria, ParasitesPathogen invasion → immune response → alveolar filling
Drug-Induced (DIP)Chemo (bleomycin, methotrexate, checkpoint inhibitors), Antibiotics (nitrofurantoin, TMP-SMX), Amiodarone, Biologics, NSAIDsDirect toxicity or hypersensitivity. Timing: days to years.
RadiationThoracic RT for breast, lung, lymphomaAcute (1-6 mo): pneumonitis. Late (>6 mo): fibrosis. Dose/volume dependent.
Autoimmune / CTDRA, SLE, Sjögren's, Scleroderma, MCTD, Vasculitis (EGPA, GPA)Immune complex, autoantibody, cellular immunity → lung injury
Hypersensitivity Pneumonitis (HP)Organic antigens: bird proteins, mold, bacteria (farmer's lung, bird fancier's)Type III/IV hypersensitivity. Acute/subacute/chronic forms.
AspirationGastric contents (chemical), oropharyngeal flora (bacterial)Acid injury + bacterial superinfection. Risk: dysphagia, decreased consciousness.
OtherEosinophilic pneumonia, organizing pneumonia (COP/BOOP), sarcoidosis, alveolar proteinosisDistinct clinicopathologic entities

Clinical Presentation

  • Respiratory: Dyspnea (exertional → rest), dry cough, pleuritic chest pain
  • Systemic: Fever, fatigue, weight loss, myalgias
  • Signs: Crackles (velcro = fibrosis), tachypnea, hypoxia, clubbing (chronic)
  • Onset: Acute (hours-days), subacute (weeks), chronic (months)

Diagnostic Workup

  1. History: Exposures (occupational, avian, mold, drugs, radiation), timeline, systemic symptoms
  2. Imaging: CXR (initial) → HRCT (gold standard: ground-glass, consolidation, centrilobular nodules, fibrosis patterns)
  3. Pulmonary Function: Restrictive pattern, ↓ DLCO
  4. Labs: CBC, BMP, LFTs, ESR/CRP, ANA, RF, ANCA, IgG subclasses, specific antibodies (anti-Jo1, etc.), precipitins (HP)
  5. Bronchoscopy + BAL: Cell count (lymphocytosis → HP, CTD, sarcoid; neutrophilia → infection, DIP, OP), cultures, cytology
  6. Surgical Lung Biopsy: If non-diagnostic. Multidisciplinary discussion (MDD) essential.

Treatment Principles

  • Remove trigger: Stop offending drug, remove antigen source, treat infection
  • Corticosteroids: Prednisone 0.5-1mg/kg/day → taper over months. Mainstay for immune-mediated.
  • Steroid-sparing: Mycophenolate, azathioprine, rituximab, cyclophosphamide (severe)
  • Supportive: O2, pulmonary rehab, antifibrotics (nintedanib/pirfenidone) for progressive fibrotic phenotype
  • Antimicrobials: Targeted for infectious etiology

Prevention

  • Vaccinations: pneumococcal, influenza, COVID, RSV (elderly)
  • Occupational: PPE, ventilation, exposure monitoring
  • Drug monitoring: baseline PFTs + serial for high-risk agents (bleomycin, checkpoint inhibitors)
  • Radiation: modern techniques (IMRT, proton) minimize lung dose
  • Aspiration: HOB elevation, dysphagia management, oral care

Key: Early recognition + trigger removal + immunosuppression (if immune-mediated) = best outcomes. Delay → fibrosis = irreversible.

Gingivitis - Related Articles